-
FDA Approves Three Generic Versions of Novartis’ Gilenya for RRMS
The U.S. FDA has approved three generic versions of Gilenya (fingolimod) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Learn more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.